Letters
Breast cancer screening debate
Independent UK Panel on Breast Cancer Screening replies to Michael Baum
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f873 (Published 13 February 2013) Cite this as: BMJ 2013;346:f873- Michael Marmot, director1
- Independent UK Panel on Breast Cancer Screening: D G Altman (University of Oxford), D A Cameron (University of Edinburgh), J A Dewar (University of Dundee), S G Thompson (University of Cambridge), Maggie Wilcox (patient advocate).
- 1UCL Institute of Health Equity, UCL Dept of Epidemiology and Public Health, London WC1E 7HB, UK
- m.marmot{at}ucl.ac.uk
Baum has raised interesting and important issues.1 The panel did not “duck” the effect of breast screening on all cause mortality. We indicated in the full report (p 32) that a 20% reduction in breast cancer mortality would reduce mortality from all cancers by only 3% and all cause mortality by 1.2%.2 The randomised trials performed lacked …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.